CHM chimeric therapeutics limited

Ann: Sponsored Research Agreement to advance CORE-NK portfolio, page-3

  1. 318 Posts.
    lightbulb Created with Sketch. 229

    Hi Steini, a bit being done on the FDA side to fast track approvals in the Cell and Gene therapy space. Good to see some changes to get these treatments to people who need them most.. faster.

    https://www.pharmtech.com/view/fda-expands-oversight-of-cell-and-gene-therapies
    https://hotcopper.com.au/data/attachments/4801/4801844-0d2636ebdfbae181c8534e3c92c60148.jpg
    https://hotcopper.com.au/data/attachments/4801/4801853-62fb939dfd6db31d05f37dd5434cbabe.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $10.07M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.28K 2.672M

Buyers (Bids)

No. Vol. Price($)
5 2758365 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14960701 24
View Market Depth
Last trade - 15.03pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.